Akari Therapeutics grants director Bazemore restricted stock units in lieu of unpaid cash retainers
Akari Therapeutics granted director Robert B. Bazemore stock options covering 60,000 American Depositary Shares on August 18, 2026. Bazemore also received grants of 13,100 American Depositary Shares on August 18, 2026, and 4,677 on October 5, 2026. The stock options comprise awards covering 45,000 and 15,000 American D